Models
SUN PHARMACEUTICAL IND LSUNPHARMAPharmaceuticals & Biotechnology
763per share · Base Model Note
Scenario
Value per share, your model763implied FY26 P/E 15.1× · EV/EBITDA 10.8×
Against CMP ₹1,840.0058.6%close of 2026-09-10
Growth the CMP implies45.0%revenue, a year for 5 years, on your other inputs
Value after FY3177%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.

Where the methods land · ₹ per share · the dashed line is the CMP

DCF, rate ±1 · growth ±1your model across the sensitivity grid
5941,099
52-week rangetraded range, a fact not a value
1,5482,047

From enterprise to equity · ₹ crore

PV of FY27FY31 free cash flow40,780
PV of terminal value1,36,498
Enterprise value1,77,278
less net debt5,689
less non-controlling interest0
add non-operating investments0
Equity value1,82,967
÷ 239.93 crore shares763
77% of the value sits after FY31. Usual when return on capital sits near the cost of capital; the 5 explicit years carry little of it.

Free cash flow, filed and modelled · ₹ '000 crore

051015FY21: ₹5,000 croreFY21FY22: ₹7,490 croreFY22FY23: ₹2,874 croreFY23FY24: ₹9,933 croreFY24FY25: ₹11,944 croreFY25FY26: ₹8,810 croreFY26FY27: ₹8,528 croreFY27FY28: ₹9,502 croreFY28FY29: ₹10,587 croreFY29FY30: ₹11,796 croreFY30FY31: ₹13,143 croreFY31
Filed, cash from operations − capexModelled free cash flow to firm

Sensitivity · ₹ per share

Down Across
WACCterminal growth4.0%4.5%5.0%5.5%6.0%
10.00%7878449129951,099
10.50%728775830897979
11.00%677716763817883
11.50%633666705751804
12.00%594623656694739
The outlined cell is your model. Green figures sit above the CMP of ₹1,840.00; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.

Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together

P10616P50754P90926
10th · 50th · 90th percentile, ₹ per share616 · 754 · 926
Draws below the CMP100%
Rank correlation with ebitda margin+0.75
Rank correlation with discount rate0.56
Rank correlation with revenue growth+0.24
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.

Projected cash flow to the firm · ₹ crore

History Forward
₹ croreFY23FY24FY25FY26FY27FY28FY29FY30FY31
Revenue43,88648,49752,57858,46264,89372,03179,95488,74998,512
growth %13.510.58.411.211.011.011.011.011.0
EBITDA11,47512,52914,59416,42418,23520,24122,46724,93927,682
margin %26.125.827.828.128.128.128.128.128.1
less depreciation(2,529)(2,557)(2,575)(2,938)(3,245)(3,602)(3,998)(4,437)(4,926)
EBIT8,9469,97212,01813,48614,99016,63918,46920,50122,756
less tax on EBIT(3,169)(3,523)(3,910)(4,340)(4,818)(5,348)
NOPAT10,31711,46812,72914,12915,68317,409
add depreciation2,5292,5572,5752,9383,2453,6023,9984,4374,926
less capex(2,086)(2,202)(2,129)(3,609)(4,023)(4,430)(4,877)(5,369)(5,911)
less working-capital build(2,161)(2,398)(2,662)(2,955)(3,280)
Free cash flow to firm2,8749,93311,9448,5289,50210,58711,79613,143
Discount factor0.9490.8550.7700.6940.625
Present value8,0948,1258,1568,1878,218
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.

The three statements, projected · ₹ crore · debt held at 4,082, dividends at 34.3% of profit

₹ croreFY26FY27FY28FY29FY30FY31
Income statement
EBIT13,48614,99016,63918,46920,50122,756
Interest at 11.4% on debt(465)(465)(465)(465)(465)
Profit before tax14,52516,17418,00420,03622,291
Profit after tax11,47911,11212,37313,77315,32717,053
Dividends(3,938)(3,811)(4,244)(4,724)(5,257)(5,849)
Balance sheet, year end
Cash9,77114,13119,03424,54130,72437,662
Working capital19,66921,83024,22826,89029,84533,126
Net block and other assets79,34680,12580,95381,83282,76483,749
Debt4,0824,0824,0824,0824,0824,082
Equity83,88091,18099,3091,08,3581,18,4281,29,632
Balance check0000(0)0
Cash flow
From operations12,19513,57615,10916,81018,698
Investing (capex)(4,023)(4,430)(4,877)(5,369)(5,911)
Financing (dividends)(3,811)(4,244)(4,724)(5,257)(5,849)
Net change in cash4,3614,9025,5076,1836,938
Free cash flow to equity8,1729,14610,23111,44012,787
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.

Scenarios side by side · ₹ per share

ScenarioTemplateGrowthMarginRateTerminal₹ / sharevs CMP
Base · editingDCF11%28.1%11.00%5%763(58.6)%
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.